Multicollinearity in prognostic factor analyses using the EORTC QLQ-C30: identification and impact on model selection
- PMID: 12483772
- DOI: 10.1002/sim.1358
Multicollinearity in prognostic factor analyses using the EORTC QLQ-C30: identification and impact on model selection
Abstract
Clinical and quality of life (QL) variables from an EORTC clinical trial of first line chemotherapy in advanced breast cancer were used in a prognostic factor analysis of survival and response to chemotherapy. For response, different final multivariate models were obtained from forward and backward selection methods, suggesting a disconcerting instability. Quality of life was measured using the EORTC QLQ-C30 questionnaire completed by patients. Subscales on the questionnaire are known to be highly correlated, and therefore it was hypothesized that multicollinearity contributed to model instability. A correlation matrix indicated that global QL was highly correlated with 7 out of 11 variables. In a first attempt to explore multicollinearity, we used global QL as dependent variable in a regression model with other QL subscales as predictors. Afterwards, standard diagnostic tests for multicollinearity were performed. An exploratory principal components analysis and factor analysis of the QL subscales identified at most three important components and indicated that inclusion of global QL made minimal difference to the loadings on each component, suggesting that it is redundant in the model. In a second approach, we advocate a bootstrap technique to assess the stability of the models. Based on these analyses and since global QL exacerbates problems of multicollinearity, we therefore recommend that global QL be excluded from prognostic factor analyses using the QLQ-C30. The prognostic factor analysis was rerun without global QL in the model, and selected the same significant prognostic factors as before.
Copyright 2002 John Wiley & Sons, Ltd.
Similar articles
-
Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancer.Eur J Cancer. 2000 Aug;36(12):1498-506. doi: 10.1016/s0959-8049(00)00144-1. Eur J Cancer. 2000. PMID: 10930797 Clinical Trial.
-
Baseline health-related quality-of-life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancer.Eur J Cancer. 2004 May;40(7):1021-30. doi: 10.1016/j.ejca.2004.01.014. Eur J Cancer. 2004. PMID: 15093577 Clinical Trial.
-
Quality of life in patients with advanced gastric cancer treated with second-line chemotherapy.Cancer Chemother Pharmacol. 2006 Feb;57(3):289-94. doi: 10.1007/s00280-005-0055-y. Epub 2005 Jul 12. Cancer Chemother Pharmacol. 2006. PMID: 16010588
-
Analysing longitudinal continuous quality of life data with dropout.Stat Methods Med Res. 2002 Feb;11(1):5-23. doi: 10.1191/0962280202sm270ra. Stat Methods Med Res. 2002. PMID: 11923994 Review.
-
Cancer-specific quality of life questionnaires: the state of the art in Europe.Eur J Cancer. 1997 Jul;33 Suppl 6:S3-7. doi: 10.1016/s0959-8049(97)00194-9. Eur J Cancer. 1997. PMID: 9404233 Review.
Cited by
-
A novel differential diagnostic model based on multiple biological parameters for immunoglobulin A nephropathy.BMC Med Inform Decis Mak. 2012 Jun 27;12:58. doi: 10.1186/1472-6947-12-58. BMC Med Inform Decis Mak. 2012. PMID: 22738421 Free PMC article.
-
Assessment of quality of life in advanced, metastatic prostate cancer: an overview of randomized phase III trials.Qual Life Res. 2017 Apr;26(4):813-822. doi: 10.1007/s11136-016-1429-9. Epub 2016 Oct 13. Qual Life Res. 2017. PMID: 27738867 Review.
-
Prognostic value of health-related quality of life in patients with metastatic pancreatic adenocarcinoma: a random forest methodology.Qual Life Res. 2016 Jul;25(7):1713-23. doi: 10.1007/s11136-015-1198-x. Epub 2015 Nov 28. Qual Life Res. 2016. PMID: 26615615 Clinical Trial.
-
Factors associated with fatigue after surgery in women with early-stage invasive breast cancer.Oncologist. 2013;18(4):467-75. doi: 10.1634/theoncologist.2012-0300. Epub 2013 Feb 12. Oncologist. 2013. PMID: 23404818 Free PMC article.
-
Estimating prognosis and palliation based on tumour marker CA 19-9 and quality of life indicators in patients with advanced pancreatic cancer receiving chemotherapy.Br J Cancer. 2010 Oct 26;103(9):1318-24. doi: 10.1038/sj.bjc.6605929. Epub 2010 Sep 28. Br J Cancer. 2010. PMID: 20877359 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical